360dx1h
Medix Biochemica Acquires Candor Bioscience
Medix said the acquisition adds to its portfolio of raw materials used for in vitro diagnostics development and improves its ability to support immunoassay developers.
360dx1h
Opko Health, BioReference Health Settle Charges of Lab Fraud
The government alleges that BioReference submitted claims to federal healthcare programs for blood tests that were not ordered by a patient's provider.
360dx1h
BioReference Health Pays $704,349 to Settle Alleged Lab Fraud
The government alleges that BioReference submitted claims to federal healthcare programs for blood tests that were not ordered by a patient's provider.
360dx17h
Abbott, BioMérieux, Cepheid, Roche, Others Gain FDA 510(k) Clearances in December
The FDA granted marketing clearances for infectious disease tests, updates to a digital pathology system, and immunoassays for chronic diseases.
360dx17h
Osang Healthcare Nabs FDA Clearance for COVID-19, Flu Combo Tests
The QuickFinder COVID-19/Flu Antigen Self-Test and the QuickFinder COVID-19/Flu Antigen Pro Test detect SARS-CoV-2, influenza A, and influenza B in swab specimens and provide results within 15 minutes ...
360dx22h
Guardant Health Reveal Assay Gets Additional Medicare Coverage for CRC Surveillance Testing
NEW YORK – Guardant Health announced Tuesday that its Guardant Reveal liquid biopsy test has received coverage from Medicare administrative contractor Palmetto GBA to monitor colorectal cancer ...